Your search returned 11 results.

Sort
Results
1.
Pembrolizumab-induced cytokine release syndrome in a patient with metastatic lung adenocarcinoma: a case report. MedStar authors:
  • Sackstein, Paul
  • Zaemes, Jacob
PMID:
  • 34330765
Year: 2021
Citation:
  • Journal for Immunotherapy of Cancer. 9(7), 2021 07.
Department:
  • Internal Medicine Residency
  • MedStar Georgetown University Hospital
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Kim C, Sackstein P, Zaemes J
2.
Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus. MedStar authors:
  • Weinstein, Arthur
PMID:
  • 24187095
Year: 2014
Citation:
  • Journal of Rheumatology. 41(2):300-9, 2014 Feb.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Rheumatology
Medline publication type:
  • Clinical Trial, Phase II
  • Journal Article
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • Chatham WW, Freimuth WW, Furie RA, Ginzler EM, LBSL02/99 Study Group, McCune WJ, McKay JD, Merrill JT, Petri MA, Stohl W, Wallace DJ, Weinstein A, Zhong ZJ
3.
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 25693012
Year: 2015
Citation:
  • New England Journal of Medicine. 372(8):724-34, 2015 Feb 19.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, CLEOPATRA Study Group, Cortes J, Ferrero JM, Heeson S, Kim SB, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM
4.
Safety profile of Pertuzumab with Trastuzumab and Docetaxel in patients from Asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: results from the phase III trial CLEOPATRA. MedStar authors:
  • Swain, Sandra M
PMID:
  • 24869931
Year: 2014
Citation:
  • Oncologist. 19(7):693-701, 2014 Jul.
Institution:
  • Washington Cancer Institute
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Chan V, Clark E, Im SA, Im YH, Knott A, Miles D, Ross G, Swain SM
5.
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. MedStar authors:
  • Priebat, Dennis A
PMID:
  • 28988646
Year: 2017
Citation:
  • Lancet Oncology. 18(11):1493-1501, 2017 Nov
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Attia S, Baker LH, Bolejack V, Burgess M, Butterfield LH, Crowley J, D'Angelo S, Davis LE, Hu J, Lazar AJ, Maki RG, Movva S, Okuno SH, Patel S, Priebat DA, Reed DR, Reinke D, Riedel RF, Rodriguez-Canales J, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wistuba II
6.
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study. MedStar authors:
  • Asch, Federico M
  • Barac, Ana
  • Cunningham, A
  • Gallagher, Christopher
  • Hofmeyer, Mark
  • Srichai, M B
  • Swain, Sandra M
PMID:
  • 30852761
Year: 2019
Citation:
  • Breast Cancer Research & Treatment. 175(3):595-603, 2019 Jun.
Institution:
  • MedStar Health
  • MedStar Health Research Institute
  • MedStar Heart & Vascular Institute
  • Washington Cancer Institute
Department:
  • Associate Dean for Research Development
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Asch FM, Barac A, Cunningham A, Dang C, Gallagher C, Geng X, Herbolsheimer P, Hofmeyer M, Isaacs C, Lynce F, Nunes R, Pohlmann PR, Shajahan-Haq A, Smith KL, Srichai MB, Swain SM, Tan MT, Timothee P, Warren R, Yu AF
7.
Bevacizumab added to neoadjuvant chemotherapy for breast cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 22276821
Year: 2012
Citation:
  • New England Journal of Medicine. 366(4):310-20, 2012 Jan 26.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
Form of publication:
  • Journal Article
All authors:
  • Adams PT, Atkins JN, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Mamounas EP, Margolese RG, Mehta RS, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA
8.
Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study. MedStar authors:
  • Swain, Sandra M
PMID:
  • 34890214
Year: 2022
Citation:
  • Journal of Clinical Oncology. 40(5):438-448, 2022 02 10.
Department:
  • Associate Dean for Research Development
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Barrios C, Bonnefoi H, Boulet T, De Laurentiis M, Ellis PA, Fehrenbacher L, Gianni L, Gralow J, Harbeck N, Huang CS, Im SA, Im YH, Ito Y, Krop IE, Liu H, Macharia H, Nowecki Z, Shah J, Song C, Swain SM, Toi M, Trask P, Winer EP
9.
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial. MedStar authors:
  • Rao, Suman
PMID:
  • 29129441
Year: 2017
Citation:
  • Lancet Oncology. 18(12):1600-1609, 2017 Dec
Institution:
  • MedStar Franklin Square Hospital
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Brahmer JR, Csoszi T, Cuffe S, Deitz AC, Fulop A, Gottfried M, Hotta K, Hui R, Lubiniecki GM, O'Brien M, Peled N, Rangwala R, Rao S, Reck M, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Zhang J
10.
SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function. MedStar authors:
  • Asch, Federico M
  • Barac, Ana
  • Lynce, Filipa
  • Swain, Sandra M
PMID:
  • 28314836
Year: 2017
Citation:
  • Oncologist. 22(5):518-525, 2017 May
Institution:
  • MedStar Heart & Vascular Institute
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Asch FM, Barac A, Dang C, Isaacs C, Lynce F, Smith KL, Swain SM, Tan MT
11.
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater. MedStar authors:
  • Rao, Suman
PMID:
  • 30620668
Year: 2019
Citation:
  • Journal of Clinical Oncology. 37(7):537-546, 2019 03 01.
Institution:
  • Medstar Franklin Square Medical Center
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Brahmer JR, Csoszi T, Cuffe S, Fulop A, Gottfried M, Hotta K, Hui R, O'Brien M, Peled N, Pietanza MC, Rao S, Reck M, Riccio A, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Vandormael K, Yang J
Pages

Powered by Koha